Form 8-K - Current report:
SEC Accession No. 0001193125-22-159792
Filing Date
2022-05-25
Accepted
2022-05-25 16:57:15
Documents
12
Period of Report
2022-05-24
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d306645d8k.htm   iXBRL 8-K 29096
  Complete submission text file 0001193125-22-159792.txt   154536

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA eq-20220524.xsd EX-101.SCH 2855
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE eq-20220524_lab.xml EX-101.LAB 18739
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eq-20220524_pre.xml EX-101.PRE 11709
6 EXTRACTED XBRL INSTANCE DOCUMENT d306645d8k_htm.xml XML 3461
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

EIN.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38692 | Film No.: 22963838
SIC: 2834 Pharmaceutical Preparations